Literature DB >> 9832115

Effects of high-dose lisinopril-isosorbide dinitrate on severe mitral regurgitation and heart failure remodeling.

A B Levine1, C Muller, T B Levine.   

Abstract

In long-term, 1-year follow-up, uptitration of angiotensin-converting enzyme inhibitor and nitrate therapy over established doses can further improve severe functional mitral regurgitation in patients with dilated cardiomyopathy due to a reversal of heart failure-related left ventricular remodeling. With marked left ventricular enlargement, >6.8 cm end-diastolic diameter, heart failure remodeling may be irreversible and resistant to further medical intervention.

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9832115     DOI： 10.1016/s0002-9149(98)00623-7

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN： 0002-9149            Impact factor:   2.778


  10 in total

1.  Left ventricular function and C-reactive protein levels in acute myocardial infarction.

Authors:  Adelaide M Arruda-Olson; Maurice Enriquez-Sarano; Francesca Bursi; Susan A Weston; Allan S Jaffe; Jill M Killian; Véronique L Roger
Journal:  Am J Cardiol       Date:  2010-04-01       Impact factor: 2.778

Review 2.  Ischemic mitral regurgitation: not only a bystander.

Authors:  Philippe Unger; Julien Magne; Chantal Dedobbeleer; Patrizio Lancellotti
Journal:  Curr Cardiol Rep       Date:  2012-04       Impact factor: 2.931

Review 3.  Functional Mitral Regurgitation: Appraising the Evidence Behind Recommended Treatment Strategies.

Authors:  Zainab Samad; Eric J Velazquez
Journal:  Curr Cardiol Rep       Date:  2016-12       Impact factor: 2.931

Review 4.  Guide to functional mitral regurgitation: a contemporary review.

Authors:  Ramya Vajapey; Deborah Kwon
Journal:  Cardiovasc Diagn Ther       Date:  2021-06

5.  Biventricular pacing: impact on exercise-induced increases in mitral insufficiency in patients with chronic heart failure.

Authors:  Klaus K Witte; Zion Sasson; Joan A Persaud; Robynn Jolliffe; Robert W Wald; John D Parker
Journal:  Can J Cardiol       Date:  2008-05       Impact factor: 5.223

Review 6.  The frequency, impact, and management of mitral regurgitation in patients with heart failure.

Authors:  Min Pu
Journal:  Curr Cardiol Rep       Date:  2006-05       Impact factor: 2.931

7.  Renin-angiotensin system inhibitors in patients with or without ischaemic mitral regurgitation after acute myocardial infarction.

Authors:  Kitae Kim; Shuichiro Kaji; Manabu Kasamoto; Ryosuke Murai; Yasuhiro Sasaki; Takeshi Kitai; Takafumi Yamane; Natsuhiko Ehara; Atsushi Kobori; Makoto Kinoshita; Yutaka Furukawa
Journal:  Open Heart       Date:  2017-12-10

8.  Evolution of mitral regurgitation in patients with heart failure referred to a tertiary heart failure clinic.

Authors:  Lotte E de Groot-de Laat; Jessy Huizer; Mattie Lenzen; Ernest Spitzer; Ben Ren; Marcel L Geleijnse; Kadir Caliskan
Journal:  ESC Heart Fail       Date:  2019-08-07

9.  Clinical impact of changes in mitral regurgitation severity after medical therapy optimization in heart failure.

Authors:  Matteo Pagnesi; Marianna Adamo; Iziah E Sama; Stefan D Anker; John G Cleland; Kenneth Dickstein; Gerasimos S Filippatos; Riccardo M Inciardi; Chim C Lang; Carlo M Lombardi; Leong L Ng; Piotr Ponikowski; Nilesh J Samani; Faiez Zannad; Dirk J van Veldhuisen; Adriaan A Voors; Marco Metra
Journal:  Clin Res Cardiol       Date:  2022-03-16       Impact factor: 6.138

Review 10.  Mitral regurgitation: lessons learned from COAPT and MITRA-Fr.

Authors:  Francesco Nappi; Antonio Nenna; Sanjeet Singh Avvtar Sing; Irina Timofeeva; Christos Mihos; Federico Gentile; Massimo Chello
Journal:  J Thorac Dis       Date:  2020-05       Impact factor: 3.005
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.